FREE CCP Consultant Pharmacist Professional Roles Questions and Answers

Question 1

A skilled nursing facility's medical director wants to implement a new policy to restrict the automatic therapeutic interchange of proton pump inhibitors (PPIs).
What is the most appropriate professional role for the consultant pharmacist in this situation?

Accepted Answer

Research and present evidence-based guidelines and cost-benefit analyses to the P&T committee to help formulate the policy.

Answer

Defer the decision entirely to the facility administrator and the director of nursing.

Answer

Implement the policy immediately as directed by the medical director without further review.

Answer

Inform the dispensing pharmacy that all therapeutic interchanges are now prohibited.

Question 2

Which of the following best describes a key difference in the regulatory requirements for a consultant pharmacist's services in a Skilled Nursing Facility (SNF) compared to most Assisted Living Facilities (ALFs)?

Accepted Answer

SNFs are federally regulated by CMS, mandating monthly medication regimen reviews, whereas ALFs are primarily regulated at the state level with more variable requirements.

Answer

The consultant pharmacist has prescriptive authority in an SNF but not in an ALF.

Answer

ALFs require monthly medication regimen reviews for every resident, while SNFs only require them quarterly.

Answer

Controlled substance destruction is managed solely by the consultant pharmacist in ALFs but by nursing staff in SNFs.

Question 3

A consultant pharmacist is tasked with providing in-service education to the nursing staff. Which of the following topics is a core professional responsibility and directly addresses a high-risk area in long-term care?

Accepted Answer

Proper use, monitoring, and risk mitigation for anticoagulant therapy.

Answer

Training on the facility's new human resources payroll software.

Answer

Instruction on advanced cardiac life support (ACLS) protocols.

Answer

Reviewing the employee benefits and retirement plan options.

Question 4

Beyond individual chart reviews, how can a consultant pharmacist leverage a facility's electronic health record (EHR) and pharmacy data to fulfill a broader professional role in quality improvement?

Accepted Answer

By generating and analyzing aggregate data reports to identify facility-wide trends in psychotropic drug use or antibiotic prescribing.

Answer

By manually changing resident allergies in the EHR without physician approval.

Answer

By using the EHR's direct messaging system to socialize with facility staff.

Answer

By printing every resident's medication administration record (MAR) for manual filing and storage.

Question 5

A facility's Pharmacy & Therapeutics (P&T) committee is developing a policy for the formulary inclusion of biosimilar medications. What is the consultant pharmacist's primary contribution to this process?

Accepted Answer

Present clinical evidence on the interchangeability, safety, and efficacy of available biosimilars to help draft guidelines for their appropriate use.

Answer

Mandate that only the least expensive biosimilar is used, regardless of indication or interchangeability.

Answer

Insist that the facility continue using only brand-name originator biologics to avoid any potential confusion.

Answer

Provide a personal opinion based on relationships with pharmaceutical company representatives.

Question 6

A consultant pharmacist is finalizing a new service agreement with a 100-bed assisted living facility. To ensure a clear professional relationship and manage expectations, which element is most critical to define within the contract?

Accepted Answer

The specific scope of services, including the frequency of reviews, committee participation, and reporting procedures.

Answer

A list of the pharmacist's preferred pharmaceutical manufacturers.

Answer

A guarantee of a 25% reduction in the facility's overall medication costs.

Answer

The personal cell phone numbers of the facility's entire nursing staff.

A skilled nursing facility's medical director wants to implement a new policy to restrict the automatic therapeutic interchange of proton pump inhibitors (PPIs).What is the most appropriate professional role for the consultant pharmacist in this situation?

A skilled nursing facility's medical director wants to implement a new policy to restrict the automatic therapeutic interchange of proton pump inhibitors (PPIs).
What is the most appropriate professional role for the consultant pharmacist in this situation?